Tenet Healthcare Corp. (THC) Misses Q4 EPS by 4c; Raises FY12 EBITDA Outlook
Tweet
Share
E-mailGet Alerts THC Hot Sheet
Price: $261.90 -1.46%
EPS Growth %: +25.1%
Financial Fact:
Discontinued operations: 0.01
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +25.1%
Financial Fact:
Discontinued operations: 0.01
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Tenet Healthcare Corp. (NYSE: THC) reported Q4 EPS of $0.10, $0.04 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $2.23 billion versus the consensus estimate of $2.4 billion.
Raised its FY12 adj-EBITDA guidance from $1.2-$1.3 billion to $1.225-$1.35 billion.
For earnings history and earnings-related data on Tenet Healthcare Corp. (THC) click here.
Raised its FY12 adj-EBITDA guidance from $1.2-$1.3 billion to $1.225-$1.35 billion.
For earnings history and earnings-related data on Tenet Healthcare Corp. (THC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Investec Double Upgrades Supreme Industries (SI:IN) to Buy
- Could Affirm be a $200 stock?
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
